Cardiac electrical instability in Erdheim-Chester disease: a case report
Andrea Urbani1, Filippo Pensotti1, Diego Castini1
1Cardiology Department and Intensive Care Unit, San Paolo Hospital, ASST Santi Paolo Carlo, University of Milan, Milan, Italy.
Insights
Erdheim-Chester disease (ECD) can affect the heart, causing electrical instability. Targeted therapies like vemurafenib have improved outcomes for patients with specific mutations.
Area of Science:
- Cardiology
- Oncology
- Genetics
Background:
- Erdheim-Chester disease (ECD) is a rare multisystemic disorder affecting various organs.
- Cardiac involvement in ECD typically manifests as pericardial effusion or right atrial masses.
- Conduction system infiltration leading to arrhythmias is an uncommon presentation of cardiac ECD.
Observation:
- This case highlights electrical instability as the primary clinical manifestation of cardiac involvement in ECD.
- The patient's presentation underscores the diverse ways ECD can impact cardiovascular function.
Findings:
- Mutations in signaling kinase proteins (BRAF, MEK, ALK) have revolutionized ECD treatment.
- Vemurafenib is approved for ECD patients with end-organ dysfunction and BRAF-V600E mutations, significantly improving prognosis.
Implications:
- This case emphasizes the importance of considering cardiac electrical complications in ECD.
- Understanding rare presentations of ECD is crucial for timely diagnosis and effective management.
- Advances in targeted therapy offer improved outcomes for patients with specific genetic profiles in ECD.
Abstract:
Erdheim-Chester disease (ECD) is a rare multisystemic disorder of non-Langerhans histiocytic cells with a pleomorphic clinical presentation. It affects bones, skin, central nervous system, pituitary gland, ocular tissue, kidneys and perirenal tissue and lungs. Cardiac involvement presents usually with pericardial effusion and right atrial masses, but rarely with conduction system infiltration and subsequent arrhythmic events. Following the discovery of mutations of activating signaling kinase proteins (BRAF, MEK, ALK), the therapeutic landscape has changed to a more precise targeted treatment. Currently vemurafenib is approved for patient with end-organ dysfunction and BRAF-V600E mutation and the prognosis has dramatically improved. Here we present a case of ECD with electrical instability as main clinically relevant manifestation of cardiac involvement.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Electrocardiogram Fundamentals
An electrocardiogram (ECG) is a diagnostic tool for identifying cardiac conditions such as arrhythmias, conduction abnormalities, and myocardial ischemia.
Definition
An electrocardiogram (ECG) visualizes the heart's electrical activity by tracing the electrical movement associated with each heartbeat on a graph or monitor. As the heart beats, an electrical wave passes through it, correlating with the cardiac cycle events.
Parts of an ECG
An ECG utilizes electrodes on the skin to...
Dysrhythmias I: Introduction
Dysrhythmias V: Evaluating Dysrhythmias
